NCT06109337 Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
| NCT ID | NCT06109337 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital of Zhejiang University |
| Condition | ADHD |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-12-04 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-12-04 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about The immune cell landscape of peripheral blood mononuclear cells in children with ADHD compared to typically developing controls. The main question it aims to answer are: 1.Testing the differences in immune cell subpopulations, protein expression and signaling pathways and cell subsets between two groups 2. Exploring the correlations between immune function in PBMC and resting-state brain functional networks in children with ADHD. Participants will be taken peripheral blood about 5 ml , cognitive assessment including Intelligence testing, Stroop color-word test and Trail making test, clinical interview and brain structural and functional MRI.
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of ADHD； Children with an IQ≥70； Both parents are Han； Agree to take venous blood with informed consent； Exclusion Criteria: Schizophrenia, mood disorder, autism, mental retardation； Obvious physical and nervous system abnormalities；
Contact & Investigator
Hu Guanghui, doctor
PRINCIPAL INVESTIGATOR
Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine
Frequently Asked Questions
Who can join the NCT06109337 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06109337 currently recruiting?
Yes, NCT06109337 is actively recruiting participants. Contact the research team at dorhushaohua@zju.edu.cn for enrollment information.
Where is the NCT06109337 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06109337 clinical trial?
NCT06109337 is sponsored by First Affiliated Hospital of Zhejiang University. The principal investigator is Hu Guanghui, doctor at Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine. The trial plans to enroll 100 participants.